Caffeine as a tool

Reviewed

Reviewed on 2026-09-19 against the evidence rules: every claim carries a grade, every claim and every safety flag carries a source, and every citation was re-resolved against the record it names. The read was delegated by the owner on 2026-09-18 and signed by the Lead on his behalf (D-295) — it is a delegated review, not the owner's own reading of the page. Every claim on it carries an evidence grade and a named weakest link. It is educational and is not medical advice.

Last reviewed 2026-08-23

The acute effect on alertness and simple speed is about as well established as anything in this section, and it is narrow. The bill is real: a dose six hours before bed still disrupts measured sleep, and withdrawal has a documented timetable.

Before anything else

Safety

Who should not
In pregnancy the figure halves: EFSA concludes that habitual intake up to 200 mg a day does not give rise to safety concerns for the fetus. That is roughly one to two cups of coffee, and it includes tea, cola, energy drinks and chocolate.
Source: Scientific Opinion on the safety of caffeine
No data in your group
For children and adolescents, EFSA states that the available information is insufficient to derive a safe caffeine intake. This site is written for adults, and no figure on this page is offered for anyone younger.
Source: Scientific Opinion on the safety of caffeine
Adverse effects
Stopping abruptly produces a documented withdrawal: headache in about half of experimental cases, onset 12 to 24 hours after the last dose, lasting two to nine days. Anyone reducing intake should expect that week and not read it as a result.
Source: A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features

Every claim, with its grade

What the evidence says, and how strong it is

A grade belongs to one claim, in one population, for one preparation — never to a compound, a food or a page. Open a grade to see the four links between the evidence and the thing you would actually do, and which of them is doing the least work.

A review of the cognitive, physical and occupational literature concludes that caffeine maintains alertness and performance, and that repeated dosing is effective for people working with restricted sleep. This is the best-replicated effect in the whole section.
In whom: Healthy adults, with the largest effects under restricted sleep
What form: Caffeine at ordinary dietary doses, taken acutely
Measured as: Alertness, vigilance and simple reaction time, within hours of a dose
Evidence grade A: Evidence supports
Why this grade
Weakest link
Study quality — design, size, blinding or replication. Nothing on this claim is thin — it is the best-replicated effect in the section — and the ceiling is that the source is a review of controlled work rather than a single pooled estimate.
What was actually studied
Adults across occupational and laboratory settings; narrative review
Detail worth knowing
Concludes that repeated administration of caffeine is an effective strategy for maintaining physical and cognitive capabilities in occupations demanding function under restricted sleep. A review, not a pooled estimate.
No source on this page establishes an effect of caffeine on reasoning or complex problem-solving in rested adults. The replicated findings are about staying alert and responding quickly, which is a smaller claim than the one usually made.
In whom: Rested, non-sleep-deprived adults
What form: Caffeine at ordinary dietary doses, taken acutely
Measured as: Reasoning, problem-solving and working memory
Evidence grade D: Human evidence insufficient
Why this grade
Weakest link
Outcome — what was measured is not what you would notice. Reasoning and complex problem-solving were not established by this source at all, so what is recorded is a gap in what was measured rather than a demonstration that nothing happens.
What was actually studied
Adults across occupational and laboratory settings; narrative review
Detail worth knowing
Concludes that repeated administration of caffeine is an effective strategy for maintaining physical and cognitive capabilities in occupations demanding function under restricted sleep. A review, not a pooled estimate.
A randomised trial gave 400 mg of caffeine at bedtime, three hours before, and six hours before. All three disrupted measured sleep, including the six-hour dose, which the authors describe as having important disruptive effects.
In whom: Adults sleeping at home at their habitual bedtimes
What form: 400 mg of caffeine — roughly two to four cups of coffee — six hours before bed
Measured as: Objectively measured sleep disruption the same night
Evidence grade B: May support
Why this grade
Weakest link
Study quality — design, size, blinding or replication. One randomised trial produced the six-hour figure, and nobody has repeated it at that timing.
What was actually studied
Adults sleeping at home at habitual bedtimes, given 400 mg caffeine
Detail worth knowing
Concludes that caffeine taken 6 hours before bedtime has important disruptive effects on sleep, supporting advice to avoid substantial caffeine for a minimum of 6 hours before sleep.
Across 57 experimental studies, headache appeared in about half of cases on stopping. Symptoms begin 12 to 24 hours after the last dose, peak between 20 and 51 hours, and last two to nine days. Reduced alertness and difficulty concentrating are among the validated symptoms.
In whom: Regular caffeine consumers
What form: Abrupt abstinence from habitual caffeine
Measured as: Headache, reduced alertness, difficulty concentrating and irritability on stopping
Evidence grade A: Evidence supports
Why this grade
Weakest link
Study quality — design, size, blinding or replication. Nothing on this claim is thin — 57 experimental studies, a validated symptom list and a timetable — and the limit is that the headline figure is the review's own tally rather than a pooled estimate.
What was actually studied
Caffeine consumers; 57 experimental and 9 survey studies
Detail worth knowing
Headache was the most common symptom, incidence about 50% in experimental studies. Onset 12–24 h after abstinence, peak intensity 20–51 h, duration 2–9 days. Validated symptoms include decreased alertness, difficulty concentrating and irritability.
The European Food Safety Authority concludes that single doses up to 200 mg — about 3 mg per kg for a 70 kg adult — and habitual intakes up to 400 mg a day do not give rise to safety concerns for healthy non-pregnant adults.
In whom: Healthy non-pregnant adults
What form: Single doses up to 200 mg; habitual intake up to 400 mg per day
Measured as: Absence of a safety concern at stated intakes
Evidence grade A: Evidence supports
Why this grade
Weakest link
Outcome — what was measured is not what you would notice. The outcome is a regulator's conclusion that stated intakes raise no safety concern, which is the strongest thing of its kind and is still a judgement over a literature rather than a measurement.
What was actually studied
General population: adults, pregnant women, children and adolescents
Detail worth knowing
Single doses up to 200 mg (about 3 mg/kg for a 70 kg adult) and habitual intakes up to 400 mg/day do not give rise to safety concerns for non-pregnant adults; up to 200 mg/day in pregnancy raises no concern for the fetus; for children and adolescents the information available is insufficient to derive a safe intake.

Sources

Everything above, and where it comes from

McLellan TM, Caldwell JA, Lieberman HR (2016). A review of caffeine's effects on cognitive, physical and occupational performance. Neuroscience & Biobehavioral Reviews 71:294–312review · Adults across occupational and laboratory settings; narrative review · checked 2026-08-23Concludes that repeated administration of caffeine is an effective strategy for maintaining physical and cognitive capabilities in occupations demanding function under restricted sleep. A review, not a pooled estimate.
Drake C, Roehrs T, Shambroom J, Roth T (2013). Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. Journal of Clinical Sleep Medicine 9(11):1195–1200rct · Adults sleeping at home at habitual bedtimes, given 400 mg caffeine · checked 2026-08-23Concludes that caffeine taken 6 hours before bedtime has important disruptive effects on sleep, supporting advice to avoid substantial caffeine for a minimum of 6 hours before sleep.
Juliano LM, Griffiths RR (2004). A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 176(1):1–29review · Caffeine consumers; 57 experimental and 9 survey studies · checked 2026-08-23Headache was the most common symptom, incidence about 50% in experimental studies. Onset 12–24 h after abstinence, peak intensity 20–51 h, duration 2–9 days. Validated symptoms include decreased alertness, difficulty concentrating and irritability.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2015). Scientific Opinion on the safety of caffeine. EFSA Journal 13(5):4102review · General population: adults, pregnant women, children and adolescents · checked 2026-08-23Single doses up to 200 mg (about 3 mg/kg for a 70 kg adult) and habitual intakes up to 400 mg/day do not give rise to safety concerns for non-pregnant adults; up to 200 mg/day in pregnancy raises no concern for the fetus; for children and adolescents the information available is insufficient to derive a safe intake.

And it costs nothing

The one thing worth doing

Move your last caffeine of the day to at least six hours before you intend to be asleep. Same dose, same drink, earlier clock. It costs nothing.

This entry describes published evidence about a substance, not a product, and makes no authorised health claim. The rules on nutrition and health claims differ by country, and this note has not yet been reviewed by a lawyer.